JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Green, H.
Right arrow Articles by Erickson, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Green, H.
Right arrow Articles by Erickson, R. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOPROPANE
Journal of Pharmacology And Experimental Therapeutics, Vol. 129, Issue 3, 237-242, 1960
Copyright © 1960 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF TRANS-2-PHENYLCYCLOPROPYLAMINE UPON NOREPINEPHRINE CONCENTRATION AND MONOAMINE OXIDASE ACTIVITY OF RAT BRAIN

Harry Green 1 and Robert W. Erickson 1

1 Research and Development Division, Smith Kline & French Laboratories, Philadelphia, Pennsylvania

A maximum increase of 85 to 90% in norepinephrine concentration of rat brain was attained about 5 hours after the oral administration of 5 mg/kg of trans-2-phenylcyclopropylamine (SKF 385) and 8 hours after the oral administration of 100 mg/kg of iproniazid. The levels returned to normal after about 7 days.

Following an oral dose of 5 mg/kg of SKF 385, the monoamine oxidase activity of rat brain was completely inhibited within 60 minutes. The inhibition remained complete until the end of the 16th hour, after which time the activity was slowly restored to normal levels in about 5 days. With 100 mg/kg of iproniazid, inhibition was complete within 3 hours and lasted until the end of the 16th hour. Normal activity was restored after 11 days.

Assuming that brain norepinephrine is metabolized chiefly via monoamine oxidase, it was estimated from the rate of increase of the amine concentration, following in vivo inhibition of the enzyme by SKF 385, that the turnover rate of norepinephrine in the brain is 17%/hour.

The possibility of the participation of the O-methyl transferase system in the metabolism of norepinephrine in rat brain is discussed.

Submitted on November 18, 1959







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1960 by the American Society for Pharmacology and Experimental Therapeutics.